A detailed history of Black Rock Inc. transactions in Dyadic International Inc stock. As of the latest transaction made, Black Rock Inc. holds 249,185 shares of DYAI stock, worth $261,644. This represents 0.0% of its overall portfolio holdings.

Number of Shares
249,185
Previous 247,462 0.7%
Holding current value
$261,644
Previous $413,000 10.9%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.39 - $2.27 $2,394 - $3,911
1,723 Added 0.7%
249,185 $368,000
Q1 2024

May 10, 2024

SELL
$1.29 - $1.67 $1,486 - $1,923
-1,152 Reduced 0.46%
247,462 $413,000
Q4 2023

Feb 13, 2024

SELL
$1.52 - $2.04 $875 - $1,175
-576 Reduced 0.23%
248,614 $400,000
Q3 2023

Nov 13, 2023

SELL
$1.71 - $2.08 $22,766 - $27,693
-13,314 Reduced 5.07%
249,190 $478,000
Q2 2023

Aug 11, 2023

BUY
$1.56 - $2.38 $7,141 - $10,895
4,578 Added 1.77%
262,504 $506,000
Q1 2023

May 12, 2023

BUY
$1.25 - $1.86 $1,693 - $2,520
1,355 Added 0.53%
257,926 $459,000
Q4 2022

Feb 13, 2023

BUY
$1.18 - $2.32 $355 - $698
301 Added 0.12%
256,571 $315,000
Q3 2022

Nov 14, 2022

BUY
$1.65 - $3.42 $1,643 - $3,406
996 Added 0.39%
256,270 $490,000
Q2 2022

Aug 12, 2022

BUY
$1.85 - $3.22 $8,482 - $14,763
4,585 Added 1.83%
255,274 $778,000
Q1 2022

May 12, 2022

SELL
$3.01 - $4.81 $8,355 - $13,352
-2,776 Reduced 1.1%
250,689 $754,000
Q4 2021

Feb 10, 2022

BUY
$3.36 - $5.34 $6,111 - $9,713
1,819 Added 0.72%
253,465 $1.15 Million
Q3 2021

Nov 09, 2021

SELL
$3.3 - $6.49 $24,420 - $48,026
-7,400 Reduced 2.86%
251,646 $1.4 Million
Q2 2021

Aug 11, 2021

BUY
$3.35 - $5.67 $867,804 - $1.47 Million
259,046 New
259,046 $929,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $29.8M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.